AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Nov. 6, 2026

Neuraxis, Inc NRXS Stock Forecast

AI-powered price prediction and analysis for Neuraxis, Inc · Total · absolute moveSwitch to Alpha

Share
X LinkedIn Reddit WhatsApp Telegram
Embed badge
AI 90-Day Forecast Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence 21.0% Spearman Correlation (n=300) · 30D 32.0%

See NRXS's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

NRXS
Fundamentals

Key Statistics

Market Cap$77M
P/B Ratio11.39x
EPS$-0.92
ROE-114.0%
Net Margin-144.4%
Revenue$5M
Current Ratio3.04x
D/E Ratio0.48x
Company

About Neuraxis, Inc

Neuraxis, Inc (NRXS) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry.

Industrial Applications and Services Electromedical & Electrotherapeutic Apparatus NYSE Small Cap
News

Latest News

  • Loading...

Where NRXS sits on the market map

Industrial Applications and Services · Electromedical & Electrotherapeutic Apparatus
Explore the map →
Industry Peers

Electromedical & Electrotherapeutic Apparatus Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
NRXS Neuraxis, Inc $77M –
MDT Medtronic Plc $134.10B 25.8x
LIVN Livanova Plc $5.02B 34.9x
ITGR Integer Holdings Corp $4.31B 43.7x
AXGN Axogen, Inc. $2.91B –
TMDX Transmedics Group, Inc. $2.39B 18.4x
CNMD Conmed Corp $1.57B 19.6x
CBLL Ceribell, Inc. $998M –
INMD Inmode Ltd. $770M 6.8x
CV Capsovision, Inc $310M 7.4x
ELMD Electromed, Inc. $224M 20.6x
FOCL Edap Tms Sa $159M –
STXS Stereotaxis, Inc. $105M –
VANI Vivani Medical, Inc. $95M –
ECOR Electrocore, Inc. $79M –
OM Outset Medical, Inc. $77M –
HYPR Hyperfine, Inc. $73M –
POCI Precision Optics Corporation, Inc. $54M –
POSC Positron Corp $54M –
QTI Qt Imaging Holdings, Inc. $30M –
ITOC Itonic Holdings Ltd $12M –
IRIX Iridex Corp $12M –
GTHP Guided Therapeutics Inc $10M –
NDRA Endra Life Sciences Inc. $8M –
ADMT Adm Tronics Unlimited, Inc. $6M –
NUWE Nuwellis, Inc. $2M –
ESMC Escalon Medical Corp $1M 1.5x
NXL Nexalin Technology, Inc. $1M –
YBGJ Yubo International Biotech Ltd N/A –
FAQ

FAQ

Is Neuraxis, Inc a good stock to buy?

Our AI analyzes Neuraxis, Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Neuraxis, Inc predictions?

For NRXS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 300 forecast dates between 2023-09-22 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 343 forecast dates between 2023-09-22 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Neuraxis, Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Neuraxis, Inc? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.